换一批Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations
第一作者：
Comer,S.D.
作者：
Comer,S.D. [1]
;
Zacny,J.P. [2]
;
Dworkin,R.H. [3]
;
Turk,D.C. [4]
;
Bigelow,G.E. [5]
;
Foltin,R.W. [6]
;
Jasinski,D.R. [7]
;
Sellers,E.M. [8]
;
Adams,E.H. [9]
;
Balster,R. [10]
;
Burke,L.B. [11]
;
Cerny,I. [12]
;
Colucci,R.D. [13]
;
Cone,E. [14]
;
Cowan,P. [15]
;
Farrar,J.T. [16]
;
DavidHaddox,J. [17]
;
Haythornthwaite,J.A. [18]
;
Hertz,S. [19]
;
Jay,G.W. [20]
;
Johanson,C.-E. [21]
;
Junor,R. [22]
;
Katz,N.P. [23]
;
Klein,M. [24]
;
Kopecky,E.A. [25]
;
Leiderman,D.B. [26]
;
McDermott,M.P. [27]
;
O'Brien,C. [28]
;
O'Connor,A.B. [29]
;
Palmer,P.P. [30]
;
Raja,S.N. [31]
;
Rappaport,B.A. [32]
;
Rauschkolb,C. ;
Rowbotham,M.C. ;
Sampaio,C. ;
Setnik,B. ;
Sokolowska,M. ;
Stauffer,J.W. ;
Walsh,S.L.
作者单位：
Endo Pharmaceuticals Inc., Chadds Ford, PA, United States
[1]
CNS Drug Consulting LLC, McLean, VA, United States
[2]
King Pharmaceuticals Inc., Cary, NC, United States
[3]
Department of Medicine, Johns Hopkins University, Baltimore, MD, United States
[4]
Department of Medicine, University of Rochester, Rochester, NY, United States
[5]
AcelRx Pharmaceuticals Inc., Redwood City, CA, United States
[6]
Department of Biostatistics, University of Rochester, Rochester, NY, United States, Department of
[7]
Johnson and Johnson Pharmaceutical Research and Development LLC., Raritan, NJ, United States
[8]
Kendle Early Phase Toronto, Formerly Decision Line Clinical Research Corporation, Toronto, ON
[9]
Department of Anesthesiology, University of Washington, Seattle, WA, United States
[10]
Pfizer Inc., New London, CT, United States
[11]
Grünenthal USA Inc., Bedminster, NJ, United States
[12]
Clinical Pharmacology and Therapeutics Laboratory, Faculdade de Medicina de Lisboa, Lisbon, Portugal
[13]
Department of Anesthesiology and Critical Care Medicine, School of Medicine, Johns Hopkins
[14]
Division on Substance Abuse, College of Physicians and Surgeons, Columbia University, New York, NY
[15]
Eisai Limited, Woodcliff Lake, NJ, United States
[16]
Durect Corporation, Cupertino, CA, United States
[17]
Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, United
[18]
American Chronic Pain Association, Rocklin, CA, United States
[19]
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA
[20]
Analgesic Research, Needham, MA, United States, Department of Anesthesiology, Tufts University
[21]
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine
[22]
United States Food and Drug Administration, Silver Spring, MD, United States
[23]
Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, United
[24]
Department of Behavioral Science, Center on Drug and Alcohol Research, University of Kentucky, KY
[25]
Department of Anesthesia and Critical Care, University of Chicago, Chicago, IL, United States
[26]
Covance, Princeton, NJ, United States
[27]
Colucci and Associates LLC, Newtown, CT, United States
[28]
Purdue Pharma L.P., Stamford, CT, United States
[29]
Psychiatry and Behavioral Sciences, Wayne State University, Detroit, MI, United States
[30]
Research Institute, California Pacific Medical Center, San Francisco, CA, United States
[31]
Department of Anesthesiology, University of Rochester, Rochester, NY, United States
[32]
发布时间
2013-11-20
- 浏览3
Pain
Pain
2315-2324页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
